These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7027252)

  • 1. Purification of guinea pig pH 3 migration inhibitory factor.
    Remold HG; McCarthy PL; Mednis AD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4088-91. PubMed ID: 7027252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two migration inhibitory factors with different chromatographic behavior and isoelectric points.
    Remold HG; Mednis AD
    J Immunol; 1977 Jun; 118(6):2015-9. PubMed ID: 325133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Products of activated lymphocytes. I. The use of radiolabeling techniques in the characterization and partial purification of the migration inhibition factor of the guinea pig.
    Sorg C; Bloom BR
    J Exp Med; 1973 Jan; 137(1):148-70. PubMed ID: 4688317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification of the cholestatic factor derived from the lymphocytes of tuberculin-sensitized guinea pigs.
    Mizoguchi Y; Ohnishi F; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1981; 16(3):260-7. PubMed ID: 7021301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of MIF and the role of macrophage associated esterases in the response of the macrophage to MIF.
    Remold HG; Mednis AD; McCarthy PL
    Adv Exp Med Biol; 1979; 114():465-8. PubMed ID: 380297
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on human migration inhibitory factor: characterization of three molecular species.
    Weiser WY; Greineder DK; Remold HG; David JR
    J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human migration inhibitory factor: purification and immunochemical characterization.
    Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
    J Exp Med; 1978 Feb; 147(2):541-53. PubMed ID: 75241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical characterization of radiolabeled lymphocyte activation products of guinea pig associated with macrophage migration inhibitory activity (MIF).
    Klinkert W; Sorg C
    Adv Exp Med Biol; 1979; 114():469-74. PubMed ID: 380298
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparsion of the properties of two antigen-induced guinea pig lymphokines.
    Ashworth LA; Eckersley BJ; Ford WH
    Int Arch Allergy Appl Immunol; 1975; 48(1):143-55. PubMed ID: 46849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification of guinea pig MIF by affinity column chromatography using macrophages.
    Onozaki K; Haga S; Miura K; Hashimoto T
    Microbiol Immunol; 1979; 23(6):533-41. PubMed ID: 114736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on guinea-pig macrophage migration inhibitory factor (MIF). II. Purification of MIF after treatment with reducing and denaturing agents.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):540-50. PubMed ID: 389497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of four lymphocyte activation products of guinea pig and their association with macrophage migration inhibitory activity (MIF).
    Klinkert W; Sorg C
    Mol Immunol; 1980 May; 17(5):555-64. PubMed ID: 7012583
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.